← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 31, 2020Last known activity
Jun 30, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 5 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Recent trials (7)
- NCT05409261CollaboratorPhase 2Jun 30, 2022
- NCT05490108Overall official - principal investigatorPhase 1/Phase 2Jun 2, 2022
- NCT05312242Study directorN/AFeb 10, 2022
- NCT05312242CollaboratorN/AFeb 10, 2022
- NCT04665791Overall official - principal investigatorN/AMar 2, 2021
- NCT04665791Lead sponsorN/AMar 2, 2021
- NCT04424511Overall official - principal investigatorPhase 3Aug 31, 2020
Details
- Last known activity
- Jun 30, 2022